Rhumbline Advisers Sells 50,284 Shares of Sabra Healthcare REIT, Inc. $SBRA
Rhumbline Advisers reduced its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 5.8% in the Q3, selling 50,284 shares and now owning 824,077 shares worth $15.36 million. Other institutional investors like Cornerstone Wealth Management LLC and AlphaQuest LLC significantly increased their positions in the company during the same period. Analyst ratings for SBRA currently average a "Moderate Buy" with a target price of $21.60, despite mixed recommendations from various firms.
Sabra Healthcare REIT (NASDAQ:SBRA) Given New $23.00 Price Target at Citizens Jmp
Citizens Jmp has increased its price target for Sabra Healthcare REIT (NASDAQ:SBRA) to $23.00 from $22.00, maintaining a "market outperform" rating and suggesting an 11.8% upside. This follows Sabra's Q1 earnings miss, although revenue was in line with expectations, and the company issued FY2026 guidance above analyst estimates. Analyst coverage for SBRA is mixed, with five "Buy" and five "Hold" ratings, and a consensus price target of $21.33.
Sabra Health Care REIT ‘off to strong start,’ with 92 percent of $240M in upcoming deals in senior living
Sabra Health Care REIT has had a strong start to the year with $240 million in investment deals, 92% of which are in senior living. The company expects to exceed its 2025 investment volume of $450 million and is focusing on expanding its managed senior housing operating portfolio. Occupancy and margins in Sabra's senior housing portfolios continue to trend positively, especially in Canada.
Analysts Are Neutral on Top Real Estate Stocks: Sabra Healthcare REIT (SBRA), Public Storage (PSA)
Analysts have issued neutral ratings for Sabra Healthcare REIT (SBRA) and Public Storage (PSA), indicating neither bullish nor bearish sentiment. Truist Financial maintained a Hold rating on Sabra Healthcare REIT with a $21.00 average price target, while Mizuho Securities reiterated a Hold rating on Public Storage with a $299.91 average price target. The reports suggest a consensus of holding these stocks rather than actively buying or selling, despite projected slight upsides.
Sabra Healthcare REIT Q1 2026 slides: Targeting 5% FFO growth with diversified portfolio
Sabra Healthcare REIT (NASDAQ: SBRA) presented its Q1 2026 investor slides, projecting approximately 5% year-over-year FFO and AFFO growth. Despite a Q4 2025 EPS miss, the company's diversified portfolio, focus on demographic trends, and strong balance sheet position it for future growth in the healthcare real estate market. Sabra emphasized its strategic alignment with operators providing compassionate care and highlighted favorable supply-demand dynamics in the skilled nursing sector.
Sabra Healthcare REIT Q1 2026 slides: Targeting 5% FFO growth with diversified portfolio
Sabra Healthcare REIT (NASDAQ:SBRA) released its Q1 2026 investor presentation, projecting a 5% year-over-year growth in normalized FFO and AFFO, despite a Q4 2025 EPS miss. The company emphasizes its diversified portfolio of 393 investments, strategic focus on favorable demographic trends like the growing elderly population, and disciplined balance sheet management. Sabra aims to capitalize on supply constraints in senior housing and skilled nursing, positioning itself for continued growth in the healthcare real estate market.
Sabra Health Care REIT, Inc. (SBRA) Shares Steady as Managed Senior Housing Drives 2025 Growth
Sabra Health Care REIT, Inc. (SBRA) saw its shares rise after reporting strong fourth-quarter and full-year 2025 results, driven by significant growth in its managed senior housing portfolio. The company provided optimistic 2026 guidance, expecting continued strong performance in net income and FFO. Despite facing sector-wide challenges like labor shortages and government reimbursement policies, Sabra's diversified portfolio and strategic investments position it for future growth amidst aging demographics.
Sabra Health Care REIT, Inc. (SBRA) Shares Steady as Managed Senior Housing Drives 2025 Growth
Sabra Health Care REIT, Inc. (SBRA) saw its shares rise by 1.22% following the release of its Q4 and full-year 2025 results, with the stock trading near its 52-week high. The company announced 2026 guidance and highlighted record growth in its managed senior housing portfolio, despite ongoing challenges from labor shortages and government reimbursement policies. Sabra's strategic focus on managed senior housing and its solid investment activity contributed to its financial performance and positive outlook.
Why Sabra Health Care REIT (SBRA) Is Up 5.6% After 2025 Results And 2026 Earnings Guidance
Sabra Health Care REIT's stock rose 5.6% following the release of its 2025 full-year results and 2026 earnings guidance. The company reported full-year revenue of US$774.63 million and net income of US$155.61 million, and reaffirmed its quarterly dividend of US$0.30 per share. Investors are keenly watching tenant performance and dividend sustainability, especially given the high payout ratio.
Sabra Health Care REIT, Inc. to Attend Citi’s 2026 Global Property CEO Conference
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that its key executives, including the Chair and CEO Rick Matros, CFO Michael Costa, CIO Darrin Smith, and EVP of Finance Lukas Hartwich, will participate in Citi’s 2026 Global Property CEO Conference. The conference is scheduled for March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. Sabra Health Care REIT operates as a self-administered real estate investment trust focused on real estate in the healthcare industry across the United States and Canada.
Citi’s 2026 Global Property CEO summit draws Sabra Health Care REIT
Sabra Health Care REIT, Inc. announced that its key executives, including CEO Rick Matros and CFO Michael Costa, will be attending Citi’s 2026 Global Property CEO Conference from March 1-4, 2026. The conference will take place at The Diplomat Beach Resort in Hollywood, Florida, where they will represent the company, which specializes in owning and investing in healthcare-related real estate across the U.S. and Canada.
Sabra Healthcare REIT stock hits 52-week high at 19.97 USD
Sabra Healthcare REIT (SBRA) has reached a new 52-week high of $19.97, demonstrating a 1-year total return of 30.28% and offering a 6.12% dividend yield, maintaining payments for 16 consecutive years. The company, with a market cap of nearly $5 billion and a "GREAT" overall rating from InvestingPro, shows strong financial health. Recent developments include the appointment of Darrin Smith as Chief Investment Officer and continued "Neutral" ratings from Cantor Fitzgerald and UBS, with price targets between $20-22, suggesting potential undervaluation.
Sabra: Q4 Earnings Snapshot
Sabra Healthcare REIT Inc. (SBRA) reported its fourth-quarter earnings, with funds from operations reaching $95.2 million, or 38 cents per share. The company also posted a net income of $27.2 million, or 11 cents per share, on revenues of $211.9 million for the quarter. For the full year, Sabra Healthcare REIT Inc. reported funds from operations of $365.4 million and total revenue of $774.6 million, and expects full-year funds from operations to be between $1.55 and $1.59 per share.
Sabra: Fourth Quarter Financial Highlights
Sabra Healthcare REIT announced its fourth-quarter financial results, reporting $95.2 million in funds from operations ($0.38 per share) and net earnings of $27.2 million ($0.11 per share). The company achieved $211.9 million in revenue for the quarter and $774.6 million for the full year, with funds from operations totaling $365.4 million annually. Sabra projects future funds from operations to be between $1.55 and $1.59 per share.
Sabra Healthcare REIT (NASDAQ:SBRA) Releases Quarterly Earnings Results, Misses Expectations By $0.28 EPS
Sabra Healthcare REIT (NASDAQ:SBRA) reported quarterly earnings of $0.38 per share, surpassing the consensus estimate by $0.01. The company's revenue for the quarter was $201.35 million, slightly missing estimates, but representing a 16.2% year-over-year increase. SBRA also declared a quarterly dividend of $0.30 per share, offering a 5.9% yield, and updated its FY 2026 EPS guidance to $1.55-$1.59.
Sabra Healthcare REIT stock hits 52-week high at 19.97 USD By Investing.com
Sabra Healthcare REIT's stock has hit a 52-week high of $19.97, reflecting a significant market resurgence with a 1-year total return of 30.28% and a 6.12% dividend yield, maintained for 16 consecutive years. The company demonstrates strong financial health with a "GREAT" InvestingPro rating and remains a key player in healthcare REITs. Recent strategic appointments and analyst price targets suggest potential for further growth.
Sabra Healthcare REIT stock hits 52-week high at 19.97 USD By Investing.com
Sabra Healthcare REIT (SBRA) recently hit a 52-week high of $19.97, marking a 1-year total return of 30.28% and offering a substantial 6.12% dividend yield, maintained for 16 consecutive years. With a market cap of nearly $5 billion and strong financial health, analysts suggest the stock may still be undervalued despite its recent surge. The company also announced a new Chief Investment Officer and received Neutral ratings from Cantor Fitzgerald and UBS.
Sabra Healthcare earnings up next: Can REIT recover from Q3 miss? By Investing.com
Sabra Healthcare REIT Inc. is set to report its fourth-quarter results, with analysts expecting a significant rebound in earnings per share and revenue after a disappointing Q3. Investors will be closely watching the company's progress on its portfolio transformation, occupancy trends in senior housing, and its ability to capitalize on sector tailwinds like an aging population and favorable government rates. The stock is currently trading near its 52-week high, suggesting investor confidence in its strategic shift and future prospects.
Sabra: Q4 Earnings Snapshot
Sabra Healthcare REIT Inc. (SBRA) reported its fourth-quarter earnings, showing funds from operations of $95.2 million, or 38 cents per share. The company posted net income of $27.2 million (11 cents per share) and revenue of $211.9 million for the quarter. For the full year, Sabra reported funds from operations of $365.4 million and revenue of $774.6 million, anticipating full-year funds from operations to be between $1.55 and $1.59 per share.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of "Hold" from Analysts
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received an average "Hold" rating from nine analysts, with a 12-month average price target of $21.11. Despite a 6.1% dividend yield, its high payout ratio of 166.67% raises sustainability concerns. Institutional investors hold 99.4% of shares, and the company's stock currently trades around $19.60 with a market capitalization of $4.89 billion.
Sabra Healthcare REIT announces executive leadership transition
This article from MSN announces an executive leadership transition at Sabra Healthcare REIT. No further details are available in the provided content.
Allianz Asset Management GmbH Buys 81,293 Shares of Sabra Healthcare REIT, Inc. $SBRA
Allianz Asset Management GmbH increased its stake in Sabra Healthcare REIT, Inc. by 9.9% in the third quarter, acquiring 81,293 additional shares to hold a total of 902,998 shares valued at approximately $16.83 million. Other institutional investors have also adjusted their positions in the company, which currently has 99.40% institutional ownership. Sabra Healthcare REIT has a market capitalization of $4.75 billion, a P/E ratio of 26.43, and recently declared a quarterly dividend of $0.30 per share.
Sabra Healthcare REIT (SBRA) Expected to Announce Earnings on Thursday
Sabra Healthcare REIT (SBRA) is expected to report its Q4 2025 earnings on Thursday, February 12th, with analysts forecasting an EPS of $0.39 and revenue of $201.965 million. The company also recently declared a quarterly dividend of $0.30 per share, representing a 6.5% dividend yield. Shares are currently trading around $18.42, and Wall Street maintains a "Hold" consensus rating with an average price target of $21.11.
Thrivent Financial for Lutherans Sells 115,983 Shares of Sabra Healthcare REIT, Inc. $SBRA
Thrivent Financial for Lutherans reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 12.3%, selling 115,983 shares and now holding 830,523 shares valued at approximately $15.48 million. The company recently announced a quarterly dividend of $0.30 per share, representing a 6.5% yield. Sabra Healthcare REIT reported quarterly earnings that beat consensus estimates and saw revenue growth of 6.7% year-over-year.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Plans Quarterly Dividend of $0.30
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) announced a quarterly dividend of $0.30 per share, payable on February 27th to shareholders of record on February 13th. While its current payout ratio of 153.8% indicates that dividends exceed earnings, analysts project a future payout ratio of 80% based on an expected $1.50 EPS next year. The company's stock recently traded near $17.87, with a market capitalization of approximately $4.45 billion.
Sabra Health Care REIT Sets February 22, 2026, for Q4 Earnings Release and Declares $0.30 Dividend
Sabra Health Care REIT, Inc. has announced that its fourth-quarter 2025 earnings report will be released on February 22, 2026, after market close, followed by a conference call on February 23, 2026. Additionally, the company's Board of Directors has declared a quarterly cash dividend of $0.30 per share payable on February 29, 2026, to shareholders of record as of February 15, 2026. Further details regarding the earnings call will be provided through official company channels.
Sabra Health Care REIT, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call; Declares Common Dividend
Sabra Health Care REIT, Inc. announced its fourth quarter 2025 earnings release date as February 12, 2026, with a conference call and webcast to follow on February 13, 2026. Additionally, the company declared a quarterly cash dividend of $0.30 per share of common stock, payable on February 27, 2026, to stockholders of record as of February 13, 2026. Sabra Health Care REIT operates as a self-administered real estate investment trust focused on the healthcare industry.
Principal Financial Group Inc. Sells 474,618 Shares of Sabra Healthcare REIT, Inc. $SBRA
Principal Financial Group Inc. has reduced its stake in Sabra Healthcare REIT, Inc. by selling 474,618 shares, although it still retains a significant holding of over 20 million shares valued at approximately $382.5 million. Sabra Healthcare REIT offers a quarterly dividend of $0.30, resulting in a 6.4% yield, but its high payout ratio of 166.67% raises questions about the long-term sustainability of this dividend. Wall Street analysts currently rate the stock as a "Hold" with an average price target of $21.11, while the company's shares are trading around $18.73.
Mitsubishi UFJ Trust & Banking Corp Has $2.77 Million Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA
Mitsubishi UFJ Trust & Banking Corp significantly reduced its stake in Sabra Healthcare REIT (SBRA) by 47.5% in Q3, ending up with 148,746 shares valued at $2.77 million. Despite this reduction, other institutional investors increased their holdings. Sabra Healthcare REIT reported Q3 EPS of $0.38, beating estimates, with revenue up 6.7% year-over-year, and analysts maintain a "Hold" rating with an average price target of $21.11.
Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by AlphaQuest LLC
AlphaQuest LLC significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 309.2% in Q3, acquiring 144,839 shares valued at $2.7 million. Despite a high dividend yield of 6.4%, which raises sustainability questions due to a 166.67% payout ratio, Sabra Healthcare REIT beat Q3 EPS estimates and provided positive FY2025 guidance. The stock currently holds an average "Hold" rating from analysts with an average target price of $21.11.
Sabra Health Care REIT, Inc. Announces Tax Treatment of 2025 Distributions
Sabra Health Care REIT, Inc. (SBRA) has announced the tax treatment for its 2025 cash distributions, detailing the breakdown of ordinary dividends, non-qualified dividends, qualified dividends, and non-dividend distributions per share for each quarter. The company noted that non-qualified ordinary dividends are also reported as Section 199A Dividends, contingent on shareholders holding shares for at least 45 days. Sabra advises shareholders to consult their tax advisors regarding these requirements.
Y Intercept Hong Kong Ltd Purchases Shares of 321,988 Sabra Healthcare REIT, Inc. $SBRA
Y Intercept Hong Kong Ltd has acquired 321,988 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the third quarter, valued at approximately $6,002,000, representing 0.13% of the company. Sabra Healthcare REIT recently announced a quarterly dividend of $0.30, providing a 6.4% yield, and reported Q3 EPS of $0.38, beating estimates. Several other institutional investors have also adjusted their holdings in Sabra Healthcare REIT.
Sabra Healthcare REIT (NASDAQ:SBRA) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen downgraded Sabra Healthcare REIT (NASDAQ:SBRA) from a "hold" to a "sell" rating in a recent research note. Despite this, the overall analyst consensus remains "Hold" with a target price of $21.11, as other firms maintain "Buy" or "Hold" ratings. The company recently reported Q3 earnings, beating EPS estimates but missing revenue, and set its FY2025 EPS guidance in line with forecasts.
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $21.00 at Truist Financial
Truist Financial increased its price target for Sabra Healthcare REIT (NASDAQ:SBRA) to $21.00 from $20.00, maintaining a "hold" rating, which suggests a potential upside of 9.15%. This comes amidst mixed analyst coverage, with a consensus "Hold" rating and a target price of $21.11 according to MarketBeat, though some firms have higher targets. The real estate investment trust recently reported a quarterly EPS of $0.38, exceeding estimates, and revenue growth of 6.7% year-over-year.
Tred Avon Family Wealth LLC Takes Position in Sabra Healthcare REIT, Inc. $SBRA
Tred Avon Family Wealth LLC has opened a new position in Sabra Healthcare REIT (NASDAQ:SBRA) by purchasing 52,507 shares valued at $979,000 during Q3. Sabra Healthcare REIT recently paid a quarterly dividend of $0.30, raising concerns about its sustainability given its 166.67% payout ratio. Analyst consensus rates the stock as a "Hold" with an average price target of $21.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Hold" from Analysts
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received a consensus "Hold" rating from nine analysts, with five rating it a "hold" and four a "buy," and an average one-year price target of $21.00. The company recently beat quarterly EPS expectations with $0.38 against a consensus of $0.37, reported revenues of $190.04 million, and announced a quarterly dividend of $0.30 per share. Despite an elevated payout ratio, institutional investors have shown increased interest in the stock.
Assessing Sabra Health Care REIT (SBRA) Valuation After Appointment Of New Chief Investment Officer
Sabra Health Care REIT (SBRA) recently appointed Darrin Smith as its new Chief Investment Officer following Talya Nevo Hacohen's retirement. The company's shares are currently trading at US$19.28, suggesting an undervalued status with a fair value of $20.82 according to the narrative analysis. This valuation is driven by specific growth and margin expectations related to a supply-demand imbalance in senior housing.
Does Sabra’s CIO Transition to Insider Darrin Smith Reshape the Bull Case for Sabra Health Care REIT (SBRA)?
Sabra Health Care REIT (SBRA) has appointed Darrin Smith as its new Chief Investment Officer, an internal promotion aimed at maintaining continuity in the company's investment strategy after the retirement of its founding CIO. This leadership change is not expected to significantly alter Sabra's immediate focus on senior housing, asset transitions, or its dividend commitment, which the company has affirmed through 2025. Investors are encouraged to consider various risk and reward scenarios due to differing fair value estimates within the Simply Wall St Community.
Does Sabra’s CIO Transition to Insider Darrin Smith Reshape the Bull Case for Sabra Health Care REIT (SBRA)?
Sabra Health Care REIT has appointed Darrin Smith as its new Chief Investment Officer, Secretary, and Executive Vice President, following the retirement of its founding CIO. This internal promotion aims to maintain continuity in Sabra's investment strategy, which focuses on senior housing and skilled nursing, and to uphold the company's dividend commitment. Investors will be watching how capital allocation and acquisitions align with these existing commitments.
Sabra Health Care REIT names Darrin Smith as new chief investment officer
Sabra Health Care REIT (NASDAQ:SBRA) has appointed Darrin Smith as its new Chief Investment Officer, Secretary, and Executive Vice President, effective January 1, 2026. Smith, who has been with Sabra since March 2020, succeeds Talya Nevo-Hacohen. The company, currently trading near its 52-week high, boasts strong financials, including 15 consecutive years of dividend payments and a 6.27% dividend yield, with analysts anticipating continued profitability and about 10% upside potential.
Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer
Sabra Health Care REIT (SBRA) stock fell 0.4% in premarket trading after the company announced Darrin Smith as its new chief investment officer and secretary, effective January 1st. CFO Michael Costa also takes on the treasurer role. Smith's base salary is set at $470,000, and the change is significant as the CIO role typically influences a REIT's investment pipeline, directly impacting cash flow and debt costs for dividend-focused companies.
Sabra Healthcare REIT Announces Executive Leadership Transition
Sabra Healthcare REIT has completed a planned leadership transition at the end of 2025, with long-serving CIO Talya Nevo-Hacohen retiring and Darrin Smith stepping in as the new Chief Investment Officer. This move aims to consolidate finance and investment leadership and ensure continuity in Sabra's investment strategy, supported by Smith's three-year employment agreement. Analysts rate SBRA as a Buy with a $22.00 price target, and TipRanks' AI Analyst Spark assesses it as Outperform due to strong financial performance and positive technical indicators.
Sabra Health Care REIT names Darrin Smith as new chief investment officer
Sabra Health Care REIT Inc. announced the appointment of Darrin Smith as its new Chief Investment Officer, Secretary, and Executive Vice President, effective January 1, 2026. Smith, who has been with Sabra since March 2020, succeeds Talya Nevo-Hacohen. The company, trading near its 52-week high, has maintained dividend payments for 15 years and analysts expect it to remain profitable.
Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement
Sabra Health Care REIT, Inc. announced the appointment of Darrin Smith as Chief Investment Officer, Secretary, and Executive Vice President, effective January 1, 2026. This appointment follows the retirement of Talya Nevo-Hacohen, who served as the former Chief Investment Officer. Mr. Smith, who previously held the role of Executive Vice President, Investments at Sabra, will lead the investment team.
Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement
Sabra Health Care REIT, Inc. has announced the appointment of Darrin Smith as its new Chief Investment Officer, Secretary, and Executive Vice President, effective January 1, 2026. This appointment follows the retirement of Talya Nevo-Hacohen, who previously held the Chief Investment Officer position. CEO Rick Matros commended both Smith and Nevo-Hacohen for their contributions to the company's investment team and pipeline.
Sabra Healthcare REIT (NASDAQ:SBRA) Upgraded at Wall Street Zen
Wall Street Zen has upgraded Sabra Healthcare REIT (NASDAQ:SBRA) from a "sell" to a "hold" rating, though the overall analyst consensus remains a "Moderate Buy." Sabra exceeded quarterly EPS expectations and saw a 6.7% revenue increase year-over-year, setting positive FY2025 EPS guidance. The company exhibits high institutional ownership, with approximately 99.40% of shares held by such investors.
Sabra Healthcare REIT, Inc. $SBRA Stock Position Raised by VIRGINIA RETIREMENT SYSTEMS ET Al
VIRGINIA RETIREMENT SYSTEMS ET Al significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 51.2% in the third quarter, bringing its total holdings to 577,800 shares valued at approximately $10.77 million. This move, alongside similar increases from other institutional investors, signifies growing confidence as institutional ownership now accounts for about 99.4% of the company's stock. The company maintains a "Moderate Buy" consensus rating from analysts with a target price of $21.00, and despite a high payout ratio of 166.67%, it offers a quarterly dividend yielding 6.3%.
Voya Investment Management LLC Increases Position in Sabra Healthcare REIT, Inc. $SBRA
Voya Investment Management LLC has increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 29.8% to 666,364 shares, valued at approximately $12.42 million. Sabra Healthcare REIT pays a quarterly dividend of $0.30, resulting in an annualized yield of about 6.5%, though its dividend payout ratio is high at 166.7%. Analyst sentiment for SBRA is mixed-to-positive, with an average rating of "Moderate Buy" and a price target of $21.00.
Sabra Health Care: Buy This High Yield For Potentially Solid Total Returns (NASDAQ:SBRA)
Sabra Health Care REIT (SBRA) is presented as a compelling dividend value investment with a 6.4% yield and strong fundamentals, including an investment-grade rating and no debt maturities until 2027. The company's SHOP segment is driving growth, with a focus on increasing its NOI mix and benefiting from demographic tailwinds and limited new supply. This positions SBRA for potential annual total returns of 11-12%.
Sound Income Strategies LLC Buys 719,716 Shares of Sabra Healthcare REIT, Inc. $SBRA
Sound Income Strategies LLC significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 42,486.2% in Q3, purchasing 719,716 additional shares to hold 721,410 shares valued at approximately $12.9 million. Sabra Healthcare REIT recently posted Q3 EPS that slightly beat expectations and announced a quarterly dividend of $0.30, representing an annualized yield of 6.4%. Analyst consensus for SBRA is a "Moderate Buy" with a target price of $21.00.
